<?xml version="1.0" encoding="UTF-8"?>
<p id="p0040">HCTs are trials in which participants are intentionally challenged (whether or not they have been vaccinated) with an infectious disease organism, such as SARS-CoV-2. The use of controlled HCTs—instead of conventional phase 3 testing—of SARS-CoV-2 vaccine candidates could accelerate the testing and potential rollout of efficacious vaccines 
 <xref rid="b0180" ref-type="bibr">[36]</xref>. However, HCT volunteers risk illness (or even death) following infection with SARS-CoV-2, so reducing these risks remains an issue. The World Health Organization (WHO) has provided guidance by outlining key criteria for the ethical acceptability of COVID-19 human challenge studies 
 <xref rid="b0185" ref-type="bibr">[37]</xref>.
</p>
